OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
YI
111, Inc.
There isn't enough reported data to score YI yet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
YI Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Strong |
YI's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
YI PE Valuation
YI has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
YI Forward outlook
There aren't enough analyst estimates for YI to show an outlook.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over YI on earnings quality, reporting a profit while its opponent remains loss making.
YI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.79 | -$0.51 |
| Q1 2026 | -$1.46 | -$0.27 |
| Q4 2025 | -$1.14 | -$0.01 |
| Q3 2025 | -$1.21 | +$3.29 |
| Q2 2025 | -$1.28 | +$4.58 |
| Q1 2025 | -$1.19 | +$5.45 |
| Q4 2024 | -$1.13 | +$5.84 |
| Q3 2024 | -$4.50 | +$0.68 |
YI is still losing money, but far less than before: $1.79 per share over the past year, against $12.49 at its worst in late 2021.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over YI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over YI on profitability, with a higher operating margin.
YI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $345.2M | -28% |
| Q1 2026 | $354.4M | -33% |
| Q4 2025 | $417.4M | -28% |
| Q3 2025 | $450.3M | -17% |
| Q2 2025 | $481.1M | -6.4% |
| Q1 2025 | $529.6M | 0% |
| Q4 2024 | $577.4M | -6.3% |
| Q3 2024 | $540.4M | -1.8% |
YI's revenue has slid since its 2022 peak: $345M last quarter, down 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1% | -1 points |
| Q1 2026 | -0.8% | -0.8 points |
| Q4 2025 | -0.2% | 0 points |
| Q3 2025 | -0.1% | -0.2 points |
| Q2 2025 | 0% | -0.1 points |
| Q1 2025 | 0% | -0.1 points |
| Q4 2024 | -0.2% | +4.8 points |
| Q3 2024 | 0.1% | +2.3 points |
YI's operating margin was −1% last quarter, down 1 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over YI on cash generation, producing positive trailing cash flow while its opponent burns cash.
YI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.7M | +$7.5M |
| Q1 2026 | -$13.8M | -181% |
| Q4 2025 | $3.8M | +$13.4M |
| Q3 2025 | $5.7M | -65% |
| Q2 2025 | -$9.2M | -166% |
| Q1 2025 | $16.9M | +3.8% |
| Q4 2024 | -$9.6M | +$21.5M |
| Q3 2024 | $16.5M | +212% |
YI has burned cash in most quarters: −$6M over the past year, against $15M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
YI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +28.3K shares |
| 1 year | +1.7% | +145K shares |
| 3 years | +5% | +418K shares |
| 5 years | +6.4% | +533K shares |
| Available history | +7.5% | +615K shares |
YI has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $2M |
| Q3 2024 | — |
YI hasn't bought back shares in the past year.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
YI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -22.3x | Net Cash |
| Q3 2025 | -14.5x | Net Cash |
| Q2 2025 | -14.1x | Net Cash |
| Q1 2025 | -14.0x | Net Cash |
| Q4 2024 | -8.4x | Net Cash |
YI has more cash than debt.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
YI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.5 | Oversold |
| Stochastic | 13.2 | Oversold |
YI's weekly RSI is 28 (oversold) and its Stochastic is 13 (oversold).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
YI PE vs Healthcare Sector
YI has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has stronger trend alignment. OSCR is above 5 of 5 weekly averages versus YI above 0 of 4.
YI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.07 | 7.2% below |
| 20 week MA | $3.47 | 18% below |
| 50 week MA | $4.79 | 41% below |
| 100 week MA | $5.76 | 51% below |
YI is in a downtrend: it's below all four of its weekly moving averages, and 51% below its 100-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over YI on returns for 2026, with the stronger performance.
YI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $11.6 | $7.35 | -36% |
| 2025 | $7.35 | $3.08 | -58% |
| 2026 YTD | $3.08 | $2.85 | -7.5% |
YI has finished every year since 2024 lower, and it's down 7.5% so far in 2026.